Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the treatment of locally advanced
esophageal squamous cell carcinoma (ESCC)with cetuximab in combination with paclitaxel,
cisplatin and radiation improve clinical outcomes.
Phase:
Phase 2
Details
Lead Sponsor:
Shandong Cancer Hospital and Institute
Collaborators:
Beijing Cancer Hospital Chinese Academy of Medical Sciences Hebei Fourth Hospital Jiangsu Cancer Institute & Hospital RenJi Hospital The Affiliated Cancer Hospital of Zhengzhou University West China Hospital